News We’re Watching: Philips Settles Recall Fallout; FDA REdI, Townhalls, Approvals

This week, Philips Respironics reached a $1.1b settlement affecting CPAP and other breathing devices. Toku announced it received US FDA breakthrough device designation for its MyKidneyAI technology. This May, the FDA will hold its REdI conference focusing on innovation in medical product development and hold another townhall focusing on considerations for selecting a sterilization modality.

"News We're Watching" Feature Image
• Source: Medtech Insight

Toku Inc. announced last week it received US Food and Drug Administration breakthrough device designation for its MyKidneyAI technology, which uses AI to analyze retinal images at routine eye exams to detect elevated chronic kidney disease risk in people with diabetes.

Most people with diabetes are not routinely screened for CKD, resulting in disease not being detected until it has developed...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Regulation

More from Policy & Regulation